Literature DB >> 6100601

Enalapril and autonomic reflexes and exercise performance.

J L Reid, J A Millar, B C Campbell.   

Abstract

Enalapril (10 mg), in young sodium replete normotensive males significantly reduced systolic and diastolic blood pressures in both the supine and erect posture without orthostatic effects. As with captopril (25 mg) erect and supine heart rate did not differ from that after inactive placebo even at the time of maximum blood pressure reduction. The absence of reflex bradycardia was not related to a sympatho-inhibitory effect as the responses to Valsalva's manoeuvre, cold stress and dynamic and isometric exercise were unchanged by enalapril. Plasma noradrenaline was not different from that found after placebo treatment. Increased parasympathetic tone may contribute to the absence of tachycardia after converting enzyme inhibitors.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6100601

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  12 in total

1.  Effect of enalapril on parasympathetic activity.

Authors:  E Boni; C Alicandri; R Fariello; A Zaninelli; A Cantalamessa; L Corda; G Muiesan
Journal:  Cardiovasc Drugs Ther       Date:  1990-02       Impact factor: 3.727

2.  Positive chronotropic activity of angiotensin II in the pithed normotensive rat is primarily due to activation of cardiac beta 1-adrenoceptors.

Authors:  J T Knape; P A van Zwieten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-08       Impact factor: 3.000

3.  Effects of single doses of quinapril and atenolol on autonomic nervous function and exercise capacity in healthy volunteers.

Authors:  I Pörsti; P Arvola; P Säynävälammi; A K Nurmi; T Metsä-Ketelä; K Koskenvuo; L A Laitinen; V Manninen; H Vapaatalo
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

4.  Hemodynamic effects of celiprolol at rest and during exercise; a comparison with enalapril.

Authors:  S Ghiringhelli; E Cozzi; D Tsialtas
Journal:  Cardiovasc Drugs Ther       Date:  1988-07       Impact factor: 3.727

5.  Effective dose range of enalapril in mild to moderate essential hypertension.

Authors:  R Bergstrand; H Herlitz; S Johansson; G Berglund; A Vedin; C Wilhelmsson; H J Gomez; V J Cirillo; J A Bolognese
Journal:  Br J Clin Pharmacol       Date:  1985-05       Impact factor: 4.335

6.  Comparison of enalapril and propranolol in essential hypertension.

Authors:  B A van Schaik; G G Geyskes; N Kettner; P Boer; E J Mees
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 7.  Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  P A Todd; R C Heel
Journal:  Drugs       Date:  1986-03       Impact factor: 9.546

8.  Cardiorespiratory effects of continuous i.v. administration of the ACE inhibitor enalaprilat in the critically ill.

Authors:  J Boldt; M Müller; M Heesen; K Härter; G Hempelmann
Journal:  Br J Clin Pharmacol       Date:  1995-11       Impact factor: 4.335

9.  Plasma enalapril levels and hormonal effects after short- and long-term administration in essential hypertension.

Authors:  C I Johnston; B J Jackson; I Larmour; R Cubella; D Casley
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

Review 10.  An overview of the clinical pharmacology of enalapril.

Authors:  R O Davies; H J Gomez; J D Irvin; J F Walker
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.